The 20 Best Cramp-Fasciculation Syndrome Doctors Near Me in Maryland, US

Dr. Elrick specializes in the care of children with neuromuscular disorders, and EMG studies in children and adults. He has special interests in genetic neuromuscular and neurodegenerative disorders and Acute Flaccid Myelitis. Dr. Elrick earned his M.D. and Ph.D. in Neuroscience at the University of Michigan Medical School, studying inherited neurodegenerative disorders of childhood. He completed residency training in Pediatrics and Child Neurology, followed by a fellowship in Neuromuscular Medicine and Johns Hopkins before joining the faculty in 2019. Dr. Elrick's laboratory research interest is in understanding mechanisms of neurodegenerative disease, especially those affecting motor neurons. He studies disorders caused by genetic mutations in the nuclear pore complex, the main pathway for transport of material in and out of the nucleus of the cell, including Triple A Syndrome. He also participates in clinical research on Acute Flaccid Myelitis (AFM), aimed at understanding susceptibility to AFM in children, and defining clinical and EMG characteristics of illness and recovery in AFM. Dr. Elrick is rated as a Distinguished provider by MediFind in the treatment of Cramp-Fasciculation Syndrome. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Cramp-Fasciculation Syndrome, Acute Flaccid Myelitis (AFM), Dysferlinopathy, and Duchenne Muscular Dystrophy. Dr. Elrick is board certified in American Board Of Psychiatry And Neurology.

James Russell is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Russell is rated as a Distinguished provider by MediFind in the treatment of Cramp-Fasciculation Syndrome. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Diabetic Neuropathy, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Cramp-Fasciculation Syndrome, and Peripheral Neuropathy.

Dr. Tom Crawford has been a member of the Department of Neurology since 1987. He is co-director of the MDA clinic for Neuromuscular Disorders and Neurologist for the Ataxia Telangiectasia Clinical Center at Johns Hopkins. His practice involves general child neurology with a principal interest in caring for children with neuromuscular, neuromotor, and ataxic disorders. Primary research interests involve the basic science and clinical characterization of two important neurologic disorders that affect children: Spinal Muscular Atrophy and Ataxia Telangiectasia. He is also actively involved in the Biology of neurofilaments by characterization of transgenic animal models. He is on the Medical and Scientific Advisory Boards of Families of Spinal Muscular Atrophy, and the Medical Advisory Committee for the Muscular Dystrophy Association. He is the Neurologist for the Ataxia Telangiectasia Clinical Center at Johns Hopkins, which has evaluated almost half of the known patients with this disorder in the United States. Additional specific clinical interests include evaluation and treatment of children with brachial plexus palsies. Dr. Crawford received his medical degree from the University of Southern California. He completed a pediatric internship and residency at the Pediatric Pavilion of the Los Angeles County / University of Southern California Medical Center, followed by a pediatric chief residency. He completed his training in Neurology with Special Qualification in Child Neurology at the Los Angeles Childrens Hospital. He then traveled east to the laboratory of Dr John Griffin at Johns Hopkins for a fellowship in Neuromuscular Disorders. Prior to medical training and Neurology residency, he majored in Psychology and Religion at Yale College. Dr. Crawford has published extensively and presented nationally and internationally. He has an active role in teaching medical students and residents in neurology. In addition, Dr. Crawford has special interest and experience in EMG studies of children and adults. Dr. Crawford is rated as an Advanced provider by MediFind in the treatment of Cramp-Fasciculation Syndrome. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), Ataxia-Telangiectasia, and Spinal Muscular Atrophy Type 2. Dr. Crawford is board certified in American Board Of Psychiatry And Neurology and American Board Of Pediatrics.

Dr. Charlotte Sumner is a Professor of Neurology and Neuroscience at Johns Hopkins University School of Medicine. Dr. Sumner cares for patients with genetically-mediated neuromuscular diseases. Her practice is notable for a focus on individuals with inherited neuromuscular disorders of peripheral nerves and motor neurons, including spinal muscular atrophy (SMA) and Charcot-Marie-Tooth (CMT) disease. She co-directs the Johns Hopkins Muscular Dystrophy Association Care Center, the Spinal Muscular Atrophy (SMA), and the Charcot-Marie-Tooth (CMT) clinics, which deliver multidisciplinary clinical care, engage in international natural history studies, and provide cutting edge therapeutics. Dr. Sumner’s research focuses on developing treatments for degenerative disorders of motor neurons and peripheral nerves. Her laboratory uses human tissues and induced pluripotent cell lines, mouse models and cultured cells to characterize disease mechanisms and develop treatments. Dr. Charlotte Sumner received her medical degree from the University of Pennsylvania School of Medicine following undergraduate studies at Princeton University. She completed internal medicine internship and neurology residency at the University of California San Francisco, after which she returned to the east coast for a neuromuscular fellowship at Johns Hopkins and a neurogenetics fellowship in the Neurogenetics Branch at the National Institute of Neurological Disorders and Stroke. She joined the neurology faculty at Johns Hopkins in 2006. Dr. Sumner is rated as an Advanced provider by MediFind in the treatment of Cramp-Fasciculation Syndrome. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Spinal Muscular Atrophy (SMA), Charcot-Marie-Tooth Disease, Primary Lateral Sclerosis, Spinal Muscular Atrophy Type 2, and Gastrostomy. Dr. Sumner is board certified in American Board Of Psychiatry And Neurology.

Lawrence Whicker is a Neurologist practicing medicine in Greenbelt, Maryland. Dr. Whicker is rated as an Advanced provider by MediFind in the treatment of Cramp-Fasciculation Syndrome. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Autosomal Dominant Partial Epilepsy with Auditory Features, Memory Loss, Seizures, and Peripheral Neuropathy.

Jay Bronder is a Neurologist practicing medicine in Potomac, Maryland. Dr. Bronder is rated as an Advanced provider by MediFind in the treatment of Cramp-Fasciculation Syndrome. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses New Daily Persistent Headache (NDPH), Migraine, Memory Loss, and Seizures.

Dennis Dey, MD, specializes in neurology and is board certified in neurology and pain medicine by the American Board of Psychiatry and Neurology. He practices at UPMC Western Maryland Neurology and Proactive Pain and Neurology. Dr. Dey completed his fellowship at Massachusetts General Hospital - Harvard Medical School, residency at MCP Hahnemann University/Drexel and Universitats Augenklinik, and medical education at Freie Universitat Berlin. Dr. Dey is rated as an Experienced provider by MediFind in the treatment of Cramp-Fasciculation Syndrome. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Cervical Spondylosis, Stroke, Headache, and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Dr. Dey is board certified in American Board Of Psychiatry And Neurology and American Board Of Psychiatry And Neurology.

Dagmara Pychynski is a Neurologist practicing medicine in Elkton, Maryland. She has been practicing medicine for over 18 years. Dr. Pychynski is rated as an Experienced provider by MediFind in the treatment of Cramp-Fasciculation Syndrome. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Generalized Tonic-Clonic Seizure, Seizures, Peripheral Neuropathy, and Memory Loss.

Dr. Leung obtained her undergraduate degree in biochemical sciences from Harvard University. While attending medical school at Duke University, she completed a year-long research fellowship studying genetic markers of late-onset Alzheimer’s disease at the National Institute on Aging as part of the NIH Clinical Research Training Program. She completed her neurology residency and clinical neurophysiology fellowship at Stanford University Medical Center, and is currently a Ph.D. candidate in the graduate training program in clinical investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Leung joined the Center for Genetic Muscle Disorders at the Kennedy Krieger Institute as a translational research fellow in 2010 and was appointed to the faculty in 2014. Her clinic specializes in electromyography and the diagnosis and treatment of hereditary muscle diseases. Dr. Leung’s research focuses on the development of imaging biomarkers and outcome measures for muscle diseases. She is the principal investigator for a longitudinal cohort study of whole-body MRI in facioscapulohumeral muscular dystrophy. Dr. Leung is also a site principal investigator for the Ionis-DMPKRx trial, a phase Ib/IIa clinical trial of a novel RNA-based therapy for myotonic muscular dystrophy. Dr. Leung is rated as an Experienced provider by MediFind in the treatment of Cramp-Fasciculation Syndrome. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Facioscapulohumeral Muscular Dystrophy (FSHD), Limb-Girdle Muscular Dystrophy Type 2I, Limb-Girdle Muscular Dystrophy, and Dysferlinopathy. Dr. Leung is board certified in American Board Of Psychiatry And Neurology.

Nicholas Maragakis treats patients with motor neuron diseases, such as amyotrophic lateral sclerosis (ALS). This care is coordinated with the Johns Hopkins Center for ALS Specialty Care, a multidisciplinary clinic with expertise in treating patients with ALS and providing support to their caregivers. He serves as medical director of the ALS Clinical Trials Unit, an extension of the multidisciplinary clinic that seeks to facilitate opportunities for patients with ALS to participate in clinical trials that could advance the treatment of this disease. Dr. Maragakis is interested in the basic science of understanding neurodegenerative diseases, as well as the translational potential of therapeutic compounds developed in the laboratory. His fundamental research interest is in using stem cells — more specifically, stem cell-derived motor neurons and glia — for understanding the development and propagation of ALS. His laboratory has been involved in creating and characterizing lines of stem cells from patients with ALS using induced pluripotent stem cell (iPSC) methodologies. The laboratory has a large library of iPSCs from patients with familial ALS and from patients with sporadic ALS. The utilization of this library of iPSCs has facilitated the development of a spinal cord-specific iPSC-astrocyte/motor neuron co-culture system, which has been leveraged for the development of assays that can be used for both the basic understanding of ALS astrocyte and motor neuron biology as well as, eventually, drug screening for ALS therapeutics. His laboratory has taken its long-standing interests in astrocyte biology, as it relates to ALS, to develop a program that investigates astrocyte-specific mechanisms as contributors to the progression (both temporally and anatomically) of disease in ALS. In this vein, there is an interest in astrocytic glutamate transporters and, more recently, astrocyte hemichannels and gap junctions. Dr. Maragakis is rated as an Experienced provider by MediFind in the treatment of Cramp-Fasciculation Syndrome. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, 15q11.2 Microdeletion, and Spinal Muscular Atrophy (SMA).

Richard Babkes is a Neurologist practicing medicine in Ellicott City, Maryland. Dr. Babkes is rated as an Experienced provider by MediFind in the treatment of Cramp-Fasciculation Syndrome. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Essential Tremor, Peripheral Neuropathy, Neuralgia, and Dravet Syndrome. Dr. Babkes is board certified in American Board Of Psychiatry And Neurology.

Dr. Jessica Nance, treats pediatric patients with neuromuscular disorders, muscular dystrophies, congenital and metabolic myopathies, Charcot-Marie-Tooth (CMT) disease, peripheral neuropathy, spinal muscular atrophy, pediatric brachial plexus and hypotonia. She has cultivated expertise in the diagnosis and management of inherited neuromuscular diseases through her experience at he National Institutes of Health with Dr. Carsten Bonnemann and in the Johns Hopkins Pediatric Neuromuscular Clinic with Dr. Tom Crawford. After completing a fellowship in neuromuscular disorders at Johns Hopkins, she is now a part of the Johns Hopkins Division of Pediatric Neurology where she will continue working in the Pediatric Neuromuscular Clinic with Dr. Crawford. She received her medical degree from Indiana University School of Medicine and completed residency training in Pediatrics and Child Neurology at Children’s National Medical Center in Washington, D.C. Dr. Nance is rated as an Experienced provider by MediFind in the treatment of Cramp-Fasciculation Syndrome. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Duchenne Muscular Dystrophy, Dysferlinopathy, Cytoplasmic Body Myopathy, and Cramp-Fasciculation Syndrome. Dr. Nance is board certified in American Board Of Psychiatry And Neurology.

Dr. Brett Morrison specializes in neuromuscular disorders in adults including peripheral neuropathies, amyotrophic lateral sclerosis, myasthenia gravis and muscle diseases. Dr. Morrison is currently the site principal investigator for clinical trials investigating new treatments for chronic inflammatory demyelinating polyneuropathy (CIDP) and painful diabetic peripheral neuropathy. Dr. Morrison's research interests include investigations into the mechanisms of nerve regeneration and common peripheral neuropathies. Current research focuses on better understanding the role of the immune system in peripheral nerves and targeting these pathways for the development of new treatments. Dr. Brett Morrison received his M.D. and Ph.D. from Mount Sinai Medical School in New York City. He completed his medical internship at the University of Maryland and residency in neurology at The Johns Hopkins Hospital. He then completed a fellowship in Clinical Neurophysiology at The Johns Hopkins Hospital. Dr. Morrison is rated as an Experienced provider by MediFind in the treatment of Cramp-Fasciculation Syndrome. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, and Spinal Muscular Atrophy (SMA). Dr. Morrison is board certified in American Board Of Psychiatry And Neurology.

Ruwani Gunawardane is a Neurologist practicing medicine in Fulton, Maryland. Dr. Gunawardane is rated as an Experienced provider by MediFind in the treatment of Cramp-Fasciculation Syndrome. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Migraine, Transient Ischemic Attack (TIA), Cerebellar Degeneration, and Delirium. Dr. Gunawardane is board certified in American Board Of Psychiatry And Neurology.

Dr. Ahmet Hoke is Professor of Neurology and Neuroscience, W. W. Smith Charitable Trust Professor of Neuroimmunology at Johns Hopkins School of Medicine, Director of the Daniel B. Drachman Division of Neuromuscular Diseases and Director of the Merkin Peripheral Neuropathy and Nerve Regeneration Center at Johns Hopkins University School of Medicine. He completed his medical training at Hacettepe University School of Medicine in Ankara, Turkey followed by his PhD studies in developmental neuroscience at Case Western Reserve University in Cleveland, Ohio, and neurology residency at Johns Hopkins Hospital. After completing his neuromuscular training at University of Calgary, Canada, he returned to Johns Hopkins University as faculty and rose through the ranks. He is the recipient of several awards including Derek Denny Brown Young Neurological Scholar Award (2005) and Wolfe Neuropathy Research prize (2018) given by the American Neurological Association, Myung Memorial Lecture Award (2017) by the Korean Neurological Association, Nejat Eczacibasi Medical Scientist Award (2019) by the Eczacibasi Foundation, Turkey, and Alan J. Gebhart Prize in Excellence in Neuropathy Research (2022) by the Peripheral Nerve Society. He is an Ex-Officio member of the Board of Directors of the American Neurological Association, and Vice-President of the Toxic Neuropathy Consortium. He serves on several editorial boards and is the Editor-in-Chief of Annals of Clinical and Translational Neurology. Dr. Hoke is rated as an Experienced provider by MediFind in the treatment of Cramp-Fasciculation Syndrome. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Wallerian Degeneration, Peripheral Neuropathy, Tomaculous Neuropathy, Spinal Muscular Atrophy with Arthrogryposis, and Prostatectomy. Dr. Hoke is board certified in American Board Of Psychiatry And Neurology.

Dr. Probasco is a professor at the Johns Hopkins University School of Medicine Department of Neurology. He is the Vice Chair for Quality, Safety, and Service for the department. He also serves as the Director of the Johns Hopkins Division of Advanced Clinical Neurology as well as the Medical Director of the Johns Hopkins Inpatient General Neurology Service. He co-directs the Johns Hopkins Encephalitis Center and the Johns Hopkins Center for Refractory Status Epilepticus and Neuroinflammation. He cares for general neurology inpatients and outpatients, specializing in autoimmune and paraneoplastic syndromes as well as neurological immune-related adverse events following immunotherapies for cancer. After completing his undergraduate studies in biochemistry at the University of New Mexico, Dr. Probasco attended the University of Oxford as a Rhodes Scholar and earned a second undergraduate degree in psychology, philosophy and physiology. He went on to earn his medical degree at the University of California, San Francisco. He completed an internship in internal medicine at Johns Hopkins Bayview Medical Center and a residency in neurology at Johns Hopkins, where he was the faculty liaison/executive chief resident. He went on to complete an instructorship in inpatient general neurology at Johns Hopkins. Dr. Probasco’s research interests include increasing care value through improving outcomes, incorporation of patient experience of disease and treatment, the efficiency of care delivery, and diagnostic test utilization in general and specifically in relation to autoimmune and paraneoplastic neurological syndromes, including encephalitis. Finally, he is interested in the management of neurological immune-related adverse events following immunotherapies for the treatment of cancer. Dr. Probasco has been recognized at the departmental, institutional, and national levels for teaching and clinical excellence, including the American Academy of Neurology’s A.B. Baker Teacher Recognition Award and the Frank L. Coulson, Jr. Award from the Johns Hopkins Medicine Miller-Coulson Academy of Clinical Excellence. He is a past graduate of the Johns Hopkins Armstrong Institute Resident Scholars (AIRS) program in Patient Safety and Quality. As a faculty member, he was inducted into the Miller-Coulson Academy of Clinical Excellence in 2019. He serves as Editor-in-Chief of NEJM Journal Watch Neurology. Videos The impact of COVID-19 on the Department of Neurology‚Äôs clinical care and medical education programs. Dr. Probasco is rated as an Experienced provider by MediFind in the treatment of Cramp-Fasciculation Syndrome. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Encephalitis, Anti-NMDA Receptor Encephalitis, Status Epilepticus, Creutzfeldt-Jakob Disease, and Gastrostomy. Dr. Probasco is board certified in American Board Of Psychiatry And Neurology.

Luke Kao is a Neurologist practicing medicine in Columbia, Maryland. Dr. Kao is rated as an Experienced provider by MediFind in the treatment of Cramp-Fasciculation Syndrome. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Distal Median Nerve Dysfunction, Common Peroneal Nerve Dysfunction, Morton Neuroma, and Neuralgia. Dr. Kao is board certified in American Board Of Psychiatry And Neurology.

Frederick Nahm is a Neurologist practicing medicine in Columbia, Maryland. Dr. Nahm is rated as an Experienced provider by MediFind in the treatment of Cramp-Fasciculation Syndrome. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Cervical Myelopathy, Dysembryoplastic Neuroepithelial Tumors (DNET), Brain Stem Cancer, and Invertebral Disc Disease. Dr. Nahm is board certified in American Board Of Psychiatry And Neurology Neurology and American Board Of Electrodiagnostic Medicine.

Richard Choi is a Neurologist practicing medicine in Glen Burnie, Maryland. He has been practicing medicine for over 18 years. Dr. Choi is rated as an Experienced provider by MediFind in the treatment of Cramp-Fasciculation Syndrome. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Stroke, Apoplexy, Subarachnoid Hemorrhage, Stent Placement, and Transmyocardial Revascularization.

Dr. Jaishri Blakeley is the Marjorie Bloomberg Tiven Professor of Neurofibromatosis in Neurology, Oncology, and Neurosurgery at Johns Hopkins School of Medicine, director of the Johns Hopkins Comprehensive Neurofibromatosis Center and director of the Neurofibromatosis Therapeutic Acceleration Program (NTAP). She is an active clinician-scientist specializing in the care of people with NF1, NF2, LZTR1, SMARC1 schwannomatoses, and primary brain tumors. Her research expertise in the development of clinical trials for nervous system tumors and specifically, early clinical-translational studies including tumor pharmacokinetic and pharmacodynamic investigations, imaging biomarkers for rare nervous system tumors, and incorporation of patient-focused, functional endpoints into efficacy studies. She has been the national or international leader of 7 clinical trials focused on therapies for glioblastoma, NF1 and NF2. In 2012 she cofounded the NTAP to dramatically shift the landscape of NF1 via necessary, efficient, and expert discovery, translational and clinical research. NTAP focuses on therapeutics, fosters collaboration, facilitates open and timely sharing of results, and streamlines the research process to accelerate therapies for plexiform and cutaneous neurofibromas. Through NTAP, Dr. Blakeley has supported and collaborated with more than 80 laboratories and research teams across the globe enabling meaningful therapeutic development for NF1-associated neoplasms and supporting the development of an exceptional community of clinician scientists focused on NF1 via the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research. Her research and programmatic efforts are all in the service of improving outcomes for the patients with NF1, NF2, schwannomatosis, and primary brain cancer for whom she is honored to provide care. Dr. Blakeley is rated as an Experienced provider by MediFind in the treatment of Cramp-Fasciculation Syndrome. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Neurofibromatosis, Schwannomatosis, Neurofibromatosis Type 2 (NF2), Neurofibromatosis Type 1 (NF1), and Laminectomy. Dr. Blakeley is board certified in American Board Of Psychiatry And Neurology.